CenterWatch Announces — Improving Diversity and Inclusion in Clinical Trials Webinar Oct. 27, 2020

Share Article

Diversity in clinical trials is critical to their success. Learn how to make trials more diverse with this timely webinar.

WCG CenterWatch

WCG CenterWatch

Improving Diversity and Inclusion in Clinical Trials
A Free CenterWatch Webinar
Tuesday, Oct. 27, 2020, 1:30 p.m.-3:00 p.m. EDT

The global COVID-19 pandemic has reignited a long-held conversation around the lack of diversity in clinical trials. Not only have minority communities continued to be underrepresented in the research studies but they’ve also now been disproportionately impacted by the global health crisis.

In this timely free webinar — hosted by Lori Abrams, Executive Director of Patient Advocacy and Diversity at WCG — we’ll discuss the increasing attention on the underrepresentation of minority participants in clinical trials and practical solutions that can better this inequitable and problematic situation. On top of the overarching need for better inclusion, greater minority participation in clinical trials will help ensure that any vaccine developed to solve the current health crisis is safe and effective.

Ken Getz — Deputy Director and Research Professor at Tufts Center for the Study of Drug Development (CSDD) — will moderate a conversation with Zak Smith — Senior Research Analyst at Tufts CSDD — and Jasmine Benger — Associate Director of Research Services at CISCRP — about this deficit of diversity in clinical trials and ways in which progress can be made to grow inclusiveness. They’ll share practical tips for reaching and connecting with minority communities as trial participants and reveal details from their own related studies.

During this free webinar, we will cover:

● The Current State of Diversity in FDA-Regulated Drug Approvals
            a.    Quantitative data around diversity in clinical trials
            b.    The magnitude of underrepresentation in pivotal trials
● Improving Inclusion
            a.    Steps toward better outreach to minority and disadvantaged
            b.    Working with local organizations and disease associations to increase
                minority participation
         c.    Achieving greater clinical research literacy and understanding within
                minority communities
         d.    Honing communication skills around the nature of clinical studies
         e.    Debunking myths and attitudes about clinical research among minority
                communities to better enable participation
● Practical Strategies for Addressing Diversity and Inclusion
         a.    Encouragement from trusted physicians
         b.    Strengthening trust in the healthcare system
         c.    Supervision by a culturally similar trial coordinator or principal
         d.    Clinical trial brochures that provide details about studies in a language
                appropriate to the community
         e. Community-vetted researchers conducting studies

Clinical trials will never be as safe and effective as they can be until researchers include minority communities in a substantial and significant way. Dig into the current state of diversity in studies and learn ways to improve inclusion.

Virtual Conference Details:
Improving Diversity and Inclusion in Clinical Trials
A Free CenterWatch Webinar
Tuesday, Oct. 27, 2020, 1:30 p.m.-3:00 p.m. EDT

Easy Ways to Register:
By phone: 888.838.5578 or 703.538.7600

About CenterWatch:
Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
Visit website